Uric acid induces oxidative stress via an activation of the renin–angiotensin system in 3T3-L1 adipocytes

Endocrine

Volumn 48, Issue 1, 2015, Pages 135-142

  Zhang, Jun xia ^a   Zhang, Yu ping ^a   Wu, Qi nan ^a   Chen, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adipocytes; Oxidative stress; Renin angiotensin system; Uric acid

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSINOGEN; ANTIOXIDANT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; REACTIVE OXYGEN METABOLITE; URIC ACID;

3T3 CELL LINE; ADIPOCYTE; ANIMAL; CARDIOVASCULAR DISEASE; DRUG EFFECTS; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

3T3-L1 CELLS; ADIPOCYTES; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; ANIMALS; ANTIOXIDANTS; CAPTOPRIL; CARDIOVASCULAR DISEASES; MICE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; URIC ACID;

EID: 84896558992     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0239-5     Document Type: Article

References (32)

1. D.I. Feig, D.H. Kang, R.J. Johnson, Uric acid and cardiovascular risk. N. Engl. J. Med. 359, 1811–1821 (2008)
2. I. Saito, T. Saruta, K. Kondo, R. Nakamura, T. Oguro, K. Yamagami, Y. Ozawa, E. Kato, Serum uric acid and the renin–angiotensin system in hypertension. J. Am. Geriatr. Soc. 26, 241–247 (1978)
3. D.I. Feig, B. Soletsky, R.J. Johnson, Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300, 924–932 (2008)
4. W. Susumu, K. Duk-Hee, F. Lili, N. Takahiko, K. John, L. Hui, Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 40, 355–360 (2002)
5. M. Mazzali, J. Kanellis, L. Han, L. Feng, Y.Y. Xia, Q. Chen, Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am. J. Physiol. Renal. Physiol. 282, F991–997 (2002)
6. D.B. Corry, P. Eslami, K. Yamamoto, M.D. Nyby, H. Makino, M.L. Tuck, Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system. J. Hypertens. 26, 269–275 (2008)
7. M.A. Yu, L.G. Sánchez-Lozada, R.J. Johnson, D.H. Kang, Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J. Hypertens. 28, 1234–1242 (2010)
8. G. Albertoni, E. Maquigussa, E. Pessoa, J.A. Barreto, F. Borges, N. Schor, Soluble uric acid increases intracellular calcium through an angiotensin II-dependent mechanism in immortalized human mesangial cells. Exp. Biol. Med. (Maywood) 235, 825–832 (2010)
9. N.S. Kalupahana, N. Moustaid-Moussa, The renin–angiotensin system: a link between obesity, inflammation and insulin resistance. Obes. Rev. 13, 136–149 (2012)
10. S. Thatcher, F. Yiannikouris, M. Gupte, L. Cassis, The adipose renin–angiotensin system: role in cardiovascular disease. Mol. Cell. Endocrinol. 302, 111–117 (2009)
11. Y.Y. Sautin, T. Nakagawa, S. Zharikov, R.J. Johnson, Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am. J. Physiol. Cell Physiol. 293, C584–596 (2007)
12. A. Kurata, H. Nishizawa, S. Kihara, N. Maeda, M. Sonoda, T. Okada, K. Ohashi, T. Hibuse, K. Fujita, A. Yasui, A. Hiuge, M. Kumada, H. Kuriyama, I. Shimomura, T. Funahashi, Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int. 70, 1717–1724 (2006)
13. S.C. Frost, M.D. Lane, Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J. Biol. Chem. 260, 2646–2652 (1985)
14. M. Fujimoto, H. Masuzaki, T. Tanaka, S. Yasue, T. Tomita, K. Okazawa, An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes. FEBS Lett. 576, 492–497 (2004)
15. J. Kanellis, S. Watanabe, J.H. Li, D.H. Kang, P. Li, T. Nakagawa, Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41, 1287–1293 (2003)
16. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw, R.W. Alexander, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141–1148 (1994)
17. B.H. Jones, M.K. Standridge, J.W. Taylor, N. Moustaid, Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am. J. Physiol. 273, R236–242 (1997)
18. C. Karlsson, K. Lindell, M. Ottosson, L. Sjostrom, B. Carlsson, L.M. Carlsson, Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J. Clin. Endocrinol. Metab. 83, 3925–3929 (1998)
19. F. Massiéra, M. Bloch-Faure, D. Ceiler, K. Murakami, A. Fukamizu, J.M. Gasc, A. Quignard-Boulange, R. Negrel, G. Ailhaud, J. Seydoux, P. Meneton, M. Teboul, Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15, 2727–2729 (2001)
20. S. Kim, M. Soltani-Bejnood, A. Quignard-Boulange, F. Massiera, M. Teboul, G. Ailhaud, J.H. Kim, N. Moustaid-Moussa, B.H. Voy, The adipose renin–angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin–angiotensin system. J. Biomed. Biotechnol. 2006, 27012 (2006)
21. G.K. Glantzounis, E.C. Tsimoyiannis, A.M. Kappas, D.A. Galaris, Uric acid and oxidative stress. Curr. Pharm. Des. 11, 4145–4151 (2005)
22. R. Stocker, J. Keaney Jr, Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381–1478 (2004)
23. R.J. Johnson, D.H. Kang, D. Feig, S. Kivlighn, J. Kanellis, S. Watanabe, K.R. Tuttle, B. Rodriguez-Iturbe, J. Herrera-Acosta, M. Mazzali, Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41, 1183–1190 (2003)
24. E. Bonora, G. Targher, M.B. Zenere, F. Saggiani, V. Cacciatori, F. Tosi, D. Travia, M.G. Zenti, P. Branzi, L. Santi, M. Muggeo, Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The verona young men atherosclerosis risk factors study. Int. J. Obes. Relat. Metab. Disord. 20, 975–980 (1996)
25. T. Ogura, K. Matsuura, Y. Matsumoto, Y. Mimura, M. Kishida, F. Otsuka, K. Tobe, Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002. Metabolism 53, 448–453 (2004)
26. S. Muraoka, T. Miura, Inhibition by uric acid of free radicals that damage biological molecules. Pharmacol. Toxicol. 93, 284–289 (2003)
27. M. Mazzali, J. Hughes, Y.G. Kim, J.A. Jefferson, D.H. Kang, K.L. Gordon, H.Y. Lan, S. Kivlighn, R.J. Johnson, Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38, 1101–1106 (2001)
28. L.G. Sánchez-Lozada, V. Soto, E. Tapia, C. Avila-Casado, Y.Y. Sautin, T. Nakagawa, M. Franco, B. Rodríguez-Iturbe, R.J. Johnson, Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am. J. Physiol. Renal. Physiol. 295, F1134–1141 (2008)
29. R.M. Touyz, X. Chen, F. Tabet, G. Yao, G. He, M.T. Quinn, P.J. Pagano, E.L. Schiffrin, Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ. Res. 90, 1205–1213 (2002)
30. R.J. Johnson, D.I. Feig, J. Herrera-Acosta, D.H. Kang, Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 45, 18–20 (2005)
31. K. Masuo, H. Kawaguchi, H. Mikami, T. Ogihara, M.L. Tuck, Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42, 474–480 (2003)
32. S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, I. Shimomura, Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114, 1752–1761 (2004)